Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST).
Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST).
复制标题
DOI:
10.1111/j.1747-4949.2009.00405.x
复制
发表时间:
2010-02
期刊:
影响因子:
--
通讯作者:
Brott TG
中科院分区:
文献类型:
--
作者:
Sheffet AJ;Roubin G;Howard G;Howard V;Moore W;Meschia JF;Hobson RW 2nd;Brott TG
Carotid endarterectomy (CEA) and medical therapy were shown superior to medical therapy alone for symptomatic (≥50%) and asymptomatic (≥60%) stenosis. Carotid angioplasty stenting (CAS) offers a less invasive alternative. Establishing safety, efficacy, and durability of CAS requires rigorous comparison with CEA in symptomatic and asymptomatic patients. The objective is to compare the efficacy of CAS versus CEA in patients with symptomatic (≥50%) or asymptomatic (≥60%) extracranial carotid stenosis. The Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) is a prospective, randomized, parallel, two-arm, multi-center trial with blinded endpoint adjudication. Primary endpoints are analyzed using standard time-to-event statistical modeling with adjustment for major baseline covariates. Primary analysis is on an intent-to-treat basis. The primary outcome is the occurrence of any stroke, myocardial infarction, or death during a 30-day peri-procedural period, and ipsilateral stroke during follow-up of up to four years. Secondary outcomes include restenosis and health-related quality of life.
登录
查看更多内容
影响因子:
1.9
作者:
OBRIEN, PC;FLEMING, TR
通讯作者:
FLEMING, TR
影响因子:
8.3
作者:
Howard VJ;Voeks JH;Lutsep HL;Mackey A;Milot G;Sam AD 2nd;Tom M;Hughes SE;Sheffet AJ;Longbottom M;Avery JB;Hobson RW 2nd;Brott TG
通讯作者:
Brott TG
影响因子:
8.3
作者:
Adams, Robert J.;Albers, Greg;Schwamm, Lee H.
通讯作者:
Schwamm, Lee H.
影响因子:
8.3
作者:
MOORE, WS;VESCERA, CL;TOOLE, JF
通讯作者:
TOOLE, JF